• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE EASYTRAK 2; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE EASYTRAK 2; IMPLANTABLE LEAD Back to Search Results
Model Number 4542
Device Problems Fracture (1260); High impedance (1291)
Patient Problems Cardiopulmonary Arrest (1765); Death (1802); Ventricular Fibrillation (2130); Heart Failure (2206); No Known Impact Or Consequence To Patient (2692)
Event Date 12/15/2016
Event Type  Death  
Manufacturer Narrative
A revision procedure was performed over a week later where the rv lead was surgically abandoned and the crt-d was explanted.The cause of the high shocking impedance remained unknown.It was noted that at the revision procedure the lv lead impedance measurements were within range and all other measurements were good.Since the lead appeared in a good position, they physician opted to leave the lv lead implanted and programmed to unipolar in hopes of resolving the issue.No additional adverse patient effects were reported.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received information that the right ventricular (rv) lead exhibited high shock impedance of 115 ohms.Review of the measurements found that the impedance measurement had been trending high for some time.Boston scientific technical services (ts) was consulted and discussed troubleshooting options.It was noted that the patient had already left the clinic.Over eight months later the patient became non-responsive and paramedics were called.Cardiopulmonary resuscitation (cpr) was performed and the patient was revived after five minutes.A remote interrogation was performed which showed the patient had ventricular fibrillation (vf) and seven shocks were administered.The patient's vf was successfully converted on the seventh shock.Further review found high out of range left ventricular (lv) pacing impedance measurements of greater than 2500 ohms along with high out of range shock impedance measurements of greater than 125 ohms for the right ventricular (rv) lead.It was noted that the lv impedance measurements had been intermittently high for the last month.An in office interrogation showed shock impedance measurements around 110 ohms.The patient was admitted for heart failure.The physician believed that the patient's increased heart failure was due to a lv lead fracture, however this has not been confirmed.The physician also noted that he believed the ineffectiveness of the first 6 shocks was due to the patient¿s decompensation, not the high shock impedance on the rv lead.
 
Event Description
Boston scientific received additional information that the patient died approximately three months after the revision procedure.An online obituary stated that the patient died peacefully at her residence, surrounded by family.The obituary also noted that contributions could be made at a local hospice facility.The cause of death was not provided.According to remote monitoring data, the patient was bi-ventricular paced 96 percent of the time since the last reset, which was (b)(6) 2016.The field representative was also contacted and noted that although the patient was being paced, capture could not be confirmed with the lv lead.Since the clinic was not aware of the patient's death, there was no further information the field representative could provide.On (b)(6) 2017 (8 days before the lv lead was reprogrammed) a remote monitoring transmission was performed.From this transmission, electrograms were available to review.The investigation is ongoing pending review by boston scientific's medical safety committee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 2
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key6476151
MDR Text Key72251119
Report Number2124215-2017-02034
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
PMA/PMN Number
P010012/S024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/20/2006
Device Model Number4542
Other Device ID NumberEASYTRAK 2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received05/08/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/20/2004
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
4470; 4542; H170; N119
Patient Outcome(s) Death; Hospitalization; Life Threatening; Required Intervention;
Patient Age79 YR
-
-